{"database": "lobbying", "table": "lobbying_activities", "rows": [[1347946, "bbb63dd0-bc3c-405f-b157-baebef8d0732", "Q4", "SQUIRE PATTON BOGGS", 30906, "RANBAXY INC.", 2012, "fourth_quarter", "PHA", "S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; Prescription Drug User Fee Reauthorization issues; H.R. 8, the American Taxpayer Relief Act.", "HOUSE OF REPRESENTATIVES,SENATE", 180000, null, 0, 0, "2013-01-20T04:25:12.937000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1347946"], "units": {}, "query_ms": 0.6861350266262889, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}